UK Renal Registry 12th Annual Report (December 2009): Chapter 14 Demography of the UK Paediatric Renal Replacement Therapy population in 2008

被引:34
|
作者
Lewis, Malcolm A. [1 ,2 ]
Shaw, Joanne [2 ]
Sinha, Manish D. [3 ]
Adalat, Shazia [3 ]
Hussain, Farida [4 ]
Castledine, Clare
van Schalkwyk, Dirk
Inward, Carol [5 ]
机构
[1] Southmead Hosp, UK Renal Registry, Bristol BS10 5NB, Avon, England
[2] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England
[3] Evelina Childrens Hosp, London, England
[4] Univ Nottingham Hosp, Nottingham NG7 2UH, England
[5] Bristol Royal Hosp Children, Bristol, Avon, England
来源
NEPHRON CLINICAL PRACTICE | 2010年 / 115卷
关键词
Aetiology; Children; Demography; End stage renal disease; Established renal failure; Incidence; Mortality; Prevalence; CHILDREN; DISEASE;
D O I
10.1159/000301237
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: To describe the demographics of the paediatric RRT population in the UK and analyse changes in demographics with time. Methods: Extraction and analysis of data from the UK Paediatric Renal Registry and the UK Renal Registry (UKRR). Results: The UK paediatric established renal failure (ERF) population in December 2008 was 905 patients. The prevalence under the age of 16 years was 56 per million age related population (pmarp) and the incidence 7.4 pmarp. The incidence and prevalence for South Asian patients was much higher than that of the White and Black populations. Renal dysplasia was the most common cause of ERF accounting for 33% of prevalent cases. Diseases with autosomal recessive inheritance were a common cause of ERF in all ethnic groups, 23.5% of prevalent and 18% of incident cases. Whilst the incidence and prevalence of diseases with autosomal recessive inheritance in the South Asian population was 3 times that of the white population, this was not the sole reason for the increased proportion of South Asian patients with ERF, as diseases with no defined inheritance were twice as common in this ethnic group than in White patients. Prevalent mortality stood at 9.4%. Most deaths were in patients presenting with ERF early in life and mortality varied markedly according to the aetiology of ERF. The proportion with new grafts from living donors has steadily risen to 54%. Children from ethnic minority groups were less likely to have an allograft and living donation was less frequent in this population. For those on dialysis, 56% were receiving peritoneal dialysis. This was the main treatment modality for patients under 4 years of age. Conclusions: The paediatric ERF population continued to expand slowly. Incidence and prevalence rates were stable and similar to other developed nations. The high incidence in patients from ethnic minority groups will lead to a greater proportion of the population being from these groups in time. To maintain the high proportion of engrafted patients it will be necessary to encourage living donation in the ethnic minority population. Case note analysis of the factors involved in mortality would be valuable.
引用
收藏
页码:C279 / C288
页数:10
相关论文
共 50 条
  • [31] UK Renal Registry 19th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2015: National and Centre-specific Analyses
    MacNeill, Stephanie J.
    Ford, Daniel
    NEPHRON, 2017, 137 : 45 - 71
  • [32] UK Renal Registry 18th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2014: National and Centre-specific Analyses
    Gilg, Julie
    Caskey, Fergus
    Fogarty, Damian
    NEPHRON, 2016, 132 : 9 - 39
  • [33] UK Renal Registry 16th Annual Report: Chapter 6 Demographics and Outcomes of Patients from Different Ethnic Groups on Renal Replacement Therapy in the UK
    Udayaraj, Udaya
    Pruthi, Rishi
    Casula, Anna
    Roderick, Paul
    NEPHRON CLINICAL PRACTICE, 2013, 125 (1-4): : 111 - 125
  • [34] UK Renal Registry 17th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2013: National and Centre-specific Analyses
    Rao, Anirudh
    Casula, Anna
    Castledine, Clare
    NEPHRON, 2015, 129 : 31 - 56
  • [35] UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses
    MacNeill, Stephanie J.
    Casula, Anna
    Shaw, Catriona
    Castledine, Clare
    NEPHRON, 2016, 132 : 41 - 67
  • [36] UK Renal Registry 17th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2013: National and Centre-specific Analyses
    Gilg, Julie
    Pruthi, Rishi
    Fogarty, Damian
    NEPHRON, 2015, 129 : 1 - 29
  • [37] UK Renal Registry 16th Annual Report: Chapter 1 UK Renal Replacement Therapy Incidence in 2012: National and Centre- specific Analyses
    Gilg, Julie
    Rao, Anirudh
    Fogarty, Damian
    NEPHRON CLINICAL PRACTICE, 2013, 125 (1-4): : 1 - 27
  • [38] UK Renal Registry 14th Annual Report: Chapter 11 Clinical, Haematological and Biochemical Parameters in Patients receiving Renal Replacement Therapy in Paediatric Centres in the UK in 2010: National and Centre-Specific Analyses
    Pruthi, Rishi
    Maxwell, Heather
    Casula, Anna
    Tse, Yincent
    Sinha, Manish D.
    O'Brien, Catherine
    Lewis, Malcolm
    Inward, Carol
    NEPHRON CLINICAL PRACTICE, 2012, 120 : C219 - C232
  • [39] UK Renal Registry 17th Annual Report: Chapter 11 Centre Variation in Access to Renal Transplantation in the UK (2008-2010)
    Pruthi, Rishi
    Curnow, Elinor
    Roderick, Paul
    Ravanan, Rommel
    NEPHRON, 2015, 129 : 247 - 256
  • [40] UK Renal Registry 15th Annual Report: Chapter 9 Centre Variation in Access to Renal Transplantation in the UK (2006-2008)
    Pruthi, Rishi
    Ravanan, Rommel
    O'Neill, John
    Roderick, Paul
    Pankhurst, Laura
    Udayaraj, Udaya
    NEPHRON CLINICAL PRACTICE, 2013, 123 : 183 - 193